NEW YORK (GenomeWeb) – Synlab Pharma said today that it has signed a collaboration agreement with Biotype to offer a Europe-wide clinical trial service for microsatellite instability and DNA polymerase epsilon/polymerase delta 1 mutation detection using Biotype's Modaplex technology.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.